RVV-X (93 kDa) and RVV-V (31 kDa), the coagulation factor X and V activating glycoproteins of Russell's Viper venom, are synthesized by the same venom gland and are capable of activating blood coagulation factors X and V, respectively. They both contain N-linked oligosaccharides but are differentially glycosylated. Cobra venom mucin is a high molecular weight, heavily glycosylated protein that is secreted abundantly by the cobra venom gland. It contains largely 0-linked oligosaccharides with terminal cc-galactosylated Le' and Le' antigenic determinants. Recent studies suggest that this mucin activates human complement in an cc-galactoside residue-dependent manner The carbohydrates released from RVV-X., RVV-V and cobra mucin were analyzed by a combination of electrospray mass spectrometry, collision-induced decomposition (CID), and for cobra mucin, specific enzymatic hydrolysis. The objective was to provide broad mass profiles and general structural features for the N-linked glycans while more specific structural details for the cobra mucin oligomers were sought, related to the presence of theantigenic (x-galactose residues. Base-released oligosaccharide alditols from cobra mucins were partitioned on Bio-Gel P 30 columns and then digested with coffee bean (x-galactosidase. By comparing the mass profiles for the smaller oligomers before and after enzyme treatment, combined with CID structural analysis, it was shown that (x-galactosidase sensitivity required the presence of a terminal hexose-hexose pair. The combination of endo-o-galactosidase and CID wasused to probe for internal structural features such as branching and tandem hexose repeats. Molecular weight distributions of the intact species of the very large oligomers are being determined by M[ALDI-TOF MS.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR010888-04
Application #
6206410
Study Section
Project Start
1999-07-01
Project End
2000-06-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Lu, Yanyan; Jiang, Yan; Prokaeva, Tatiana et al. (2017) Oxidative Post-Translational Modifications of an Amyloidogenic Immunoglobulin Light Chain Protein. Int J Mass Spectrom 416:71-79
Sethi, Manveen K; Zaia, Joseph (2017) Extracellular matrix proteomics in schizophrenia and Alzheimer's disease. Anal Bioanal Chem 409:379-394
Hu, Han; Khatri, Kshitij; Zaia, Joseph (2017) Algorithms and design strategies towards automated glycoproteomics analysis. Mass Spectrom Rev 36:475-498
Ji, Yuhuan; Bachschmid, Markus M; Costello, Catherine E et al. (2016) S- to N-Palmitoyl Transfer During Proteomic Sample Preparation. J Am Soc Mass Spectrom 27:677-85
Hu, Han; Khatri, Kshitij; Klein, Joshua et al. (2016) A review of methods for interpretation of glycopeptide tandem mass spectral data. Glycoconj J 33:285-96
Pu, Yi; Ridgeway, Mark E; Glaskin, Rebecca S et al. (2016) Separation and Identification of Isomeric Glycans by Selected Accumulation-Trapped Ion Mobility Spectrometry-Electron Activated Dissociation Tandem Mass Spectrometry. Anal Chem 88:3440-3
Wang, Yun Hwa Walter; Meyer, Rosana D; Bondzie, Philip A et al. (2016) IGPR-1 Is Required for Endothelial Cell-Cell Adhesion and Barrier Function. J Mol Biol 428:5019-5033
Srinivasan, Srimathi; Chitalia, Vipul; Meyer, Rosana D et al. (2015) Hypoxia-induced expression of phosducin-like 3 regulates expression of VEGFR-2 and promotes angiogenesis. Angiogenesis 18:449-62
Yu, Xiang; Sargaeva, Nadezda P; Thompson, Christopher J et al. (2015) In-Source Decay Characterization of Isoaspartate and ?-Peptides. Int J Mass Spectrom 390:101-109
Steinhorn, Benjamin S; Loscalzo, Joseph; Michel, Thomas (2015) Nitroglycerin and Nitric Oxide--A Rondo of Themes in Cardiovascular Therapeutics. N Engl J Med 373:277-80

Showing the most recent 10 out of 253 publications